364 related articles for article (PubMed ID: 25854670)
1. Treatment and prevention of paronychia using a new combination of topicals: report of 30 cases.
Gianni C
G Ital Dermatol Venereol; 2015 Aug; 150(4):357-62. PubMed ID: 25854670
[TBL] [Abstract][Full Text] [Related]
2. Chronic paronychia--putting a finger on the evidence.
Montgomery BD
Aust Fam Physician; 2006 Oct; 35(10):811, 813. PubMed ID: 17019458
[TBL] [Abstract][Full Text] [Related]
3. Paronychia.
Daniel CR
Dermatol Clin; 1985 Jul; 3(3):461-4. PubMed ID: 3830507
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic paronychia.
Rigopoulos D; Larios G; Gregoriou S; Alevizos A
Am Fam Physician; 2008 Feb; 77(3):339-46. PubMed ID: 18297959
[TBL] [Abstract][Full Text] [Related]
5. Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen.
Daniel CR; Daniel MP; Daniel J; Sullivan S; Bell FE
Cutis; 2004 Jan; 73(1):81-5. PubMed ID: 14964637
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the topical antimycotic treatment in psoriatic onychopathy with severe perionychia].
Santagostino L; Giorgetti P; Di Cintio R; Albanese G
G Ital Dermatol Venereol; 1988 May; 123(5):253-9. PubMed ID: 3209245
[No Abstract] [Full Text] [Related]
7. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
Tosti A; Piraccini BM; Ghetti E; Colombo MD
J Am Acad Dermatol; 2002 Jul; 47(1):73-6. PubMed ID: 12077585
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
Subissi A; Monti D; Togni G; Mailland F
Drugs; 2010 Nov; 70(16):2133-52. PubMed ID: 20964457
[TBL] [Abstract][Full Text] [Related]
9. Clinical and cytologic features of antibiotic-resistant acute paronychia.
Durdu M; Ruocco V
J Am Acad Dermatol; 2014 Jan; 70(1):120-6.e1. PubMed ID: 24355264
[TBL] [Abstract][Full Text] [Related]
10. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
11. Chronic paronychia and onycholysis: a thirteen-year experience.
Daniel CR; Daniel MP; Daniel CM; Sullivan S; Ellis G
Cutis; 1996 Dec; 58(6):397-401. PubMed ID: 8970776
[TBL] [Abstract][Full Text] [Related]
12. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans.
Gallup E; Plott T;
J Drugs Dermatol; 2005; 4(1):29-34. PubMed ID: 15696982
[TBL] [Abstract][Full Text] [Related]
14. Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial.
Veraldi S; Menter A; Innocenti M
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):290-6. PubMed ID: 18269596
[TBL] [Abstract][Full Text] [Related]
15. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
Mahdy RA; Nada WM; Wageh MM
J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of role of Candida in patients with chronic paronychia.
Bahunuthula RK; Thappa DM; Kumari R; Singh R; Munisamy M; Parija SC
Indian J Dermatol Venereol Leprol; 2015; 81(5):485-90. PubMed ID: 26087081
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
Goldust M; Rezaee E; Masoudnia S; Raghifar R
Ann Parasitol; 2013; 59(3):119-23. PubMed ID: 24881281
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of sertaconazole cream (2 %) in diaper dermatitis candidiasis.
Bonifaz A; Tirado-Sánchez A; Graniel MJ; Mena C; Valencia A; Ponce-Olivera RM
Mycopathologia; 2013 Apr; 175(3-4):249-54. PubMed ID: 23546772
[TBL] [Abstract][Full Text] [Related]
20. Onychomadesis secondary to allergic contact dermatitis to tioconazole contained in a nail lacquer: Description of three cases.
Romita P; Guarneri F; De Prezzo S; Dimauro D; Ambrogio F; Bonamonte D; Foti C
Contact Dermatitis; 2020 Apr; 82(4):242-243. PubMed ID: 31800097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
